Stock XTCY XTACY THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Xtacy Therapeutics Corp.

Equities

XTCY

CA98423G1072

Market Closed - Canadian Securities Exchange
Other stock markets
 20:26:03 05/06/2024 BST 		5-day change 1st Jan Change
0.04 CAD 0.00% Intraday chart for Xtacy Therapeutics Corp. -27.27% -11.11%
05-29 Xtacy Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024 CI
04-17 Xtacy Therapeutics Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Investment Management & Fund Operators

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
XTACY THERAPEUTICS CORP. Stock Xtacy Therapeutics Corp.
 1.59M - - - - -
BLACKROCK, INC. Stock BlackRock, Inc.
 116B
BROOKFIELD CORPORATION Stock Brookfield Corporation
 65.5B - - - - -
APOLLO GLOBAL MANAGEMENT, INC. Stock Apollo Global Management, Inc.
 64.28B - -
BANK OF NEW YORK MELLON CORPORATION (THE) Stock Bank of New York Mellon Corporation (The)
 44.8B -
AMERIPRISE FINANCIAL, INC. Stock Ameriprise Financial, Inc.
 42.26B
  1. Stock Market
  2. Equities
  3. XTCY Stock
  4. Charts Xtacy Therapeutics Corp.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW